Antibody-Secreting Cells To Diagnose Mycobacterium tuberculosis Infection in Children in Pakistan
Reliance on microbiologic methods to diagnose infection is a suboptimal approach for children due in part to the paucibacillary nature of the disease. A blood-based biomarker assay, such as the mycobacterial-antibody-secreting cell (MASC) assay, could be a major advance for the field of study of ped...
Saved in:
Published in: | mSphere Vol. 5; no. 1 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
American Society for Microbiology
05-02-2020
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Reliance on microbiologic methods to diagnose
infection is a suboptimal approach for children due in part to the paucibacillary nature of the disease. A blood-based biomarker assay, such as the mycobacterial-antibody-secreting cell (MASC) assay, could be a major advance for the field of study of pediatric tuberculosis (TB). Children <15 years of age with clinical concern for TB and age-matched children with no concern for TB were enrolled from outpatient clinics in Karachi, Pakistan. MASC, ferritin, and C-reactive protein (CRP) assays were performed, and results were compared among cases and controls, as well as among children with a case definition of "confirmed TB," "probable TB," or "possible TB." MASC responses were significantly higher among children with TB than among controls (0.41 optical density [OD] versus 0.28 OD, respectively,
< 0.001), and the differences were largely driven by the data from children with confirmed TB (
= 0.002). Ferritin and CRP values were significantly higher among those with confirmed TB than among those with the other disease states and controls (
= 0.004 and
= 0.019, respectively). The use of the MASC assay as a blood-based biomarker for TB disease shows some promise among children with microbiologically confirmed disease; however, the performance characteristics for the majority of young children with unconfirmed TB were suboptimal in this cohort.
Tuberculosis (TB) in children represents a missed opportunity for diagnosis and preventive therapy. The magnitude or burden of disease in children is not fully understood due to our limitations with respect to exploring sensitive diagnostic algorithms. In a setting of TB endemicity in Pakistan, we carried out a proof-of-concept study to evaluate for the first time the performance of B cell analyses by the use of well-defined diagnostic criteria and NIH consensus guidelines as "culture-confirmed," "probable," and "possible" TB groups. In contrast to detection of serum antibody, we focused on mycobacterial-antibody-secreting cell (MASC) detection as a marker of active disease in children with a strong suspicion of TB. Further work exploring a larger panel of inflammatory biomarkers and enrichment of B cells with the objective of increasing the sensitivity of the current MASC assay would lead to the development of a field-friendly assay for timely diagnosis of childhood TB. |
---|---|
AbstractList | ABSTRACT Reliance on microbiologic methods to diagnose Mycobacterium tuberculosis infection is a suboptimal approach for children due in part to the paucibacillary nature of the disease. A blood-based biomarker assay, such as the mycobacterial-antibody-secreting cell (MASC) assay, could be a major advance for the field of study of pediatric tuberculosis (TB). Children <15 years of age with clinical concern for TB and age-matched children with no concern for TB were enrolled from outpatient clinics in Karachi, Pakistan. MASC, ferritin, and C-reactive protein (CRP) assays were performed, and results were compared among cases and controls, as well as among children with a case definition of “confirmed TB,” “probable TB,” or “possible TB.” MASC responses were significantly higher among children with TB than among controls (0.41 optical density [OD] versus 0.28 OD, respectively, P < 0.001), and the differences were largely driven by the data from children with confirmed TB (P = 0.002). Ferritin and CRP values were significantly higher among those with confirmed TB than among those with the other disease states and controls (P = 0.004 and P = 0.019, respectively). The use of the MASC assay as a blood-based biomarker for TB disease shows some promise among children with microbiologically confirmed disease; however, the performance characteristics for the majority of young children with unconfirmed TB were suboptimal in this cohort. IMPORTANCE Tuberculosis (TB) in children represents a missed opportunity for diagnosis and preventive therapy. The magnitude or burden of disease in children is not fully understood due to our limitations with respect to exploring sensitive diagnostic algorithms. In a setting of TB endemicity in Pakistan, we carried out a proof-of-concept study to evaluate for the first time the performance of B cell analyses by the use of well-defined diagnostic criteria and NIH consensus guidelines as “culture-confirmed,” “probable,” and “possible” TB groups. In contrast to detection of serum antibody, we focused on mycobacterial-antibody-secreting cell (MASC) detection as a marker of active disease in children with a strong suspicion of TB. Further work exploring a larger panel of inflammatory biomarkers and enrichment of B cells with the objective of increasing the sensitivity of the current MASC assay would lead to the development of a field-friendly assay for timely diagnosis of childhood TB. Tuberculosis (TB) in children represents a missed opportunity for diagnosis and preventive therapy. The magnitude or burden of disease in children is not fully understood due to our limitations with respect to exploring sensitive diagnostic algorithms. In a setting of TB endemicity in Pakistan, we carried out a proof-of-concept study to evaluate for the first time the performance of B cell analyses by the use of well-defined diagnostic criteria and NIH consensus guidelines as “culture-confirmed,” “probable,” and “possible” TB groups. In contrast to detection of serum antibody, we focused on mycobacterial-antibody-secreting cell (MASC) detection as a marker of active disease in children with a strong suspicion of TB. Further work exploring a larger panel of inflammatory biomarkers and enrichment of B cells with the objective of increasing the sensitivity of the current MASC assay would lead to the development of a field-friendly assay for timely diagnosis of childhood TB. Reliance on microbiologic methods to diagnose Mycobacterium tuberculosis infection is a suboptimal approach for children due in part to the paucibacillary nature of the disease. A blood-based biomarker assay, such as the mycobacterial-antibody-secreting cell (MASC) assay, could be a major advance for the field of study of pediatric tuberculosis (TB). Children <15 years of age with clinical concern for TB and age-matched children with no concern for TB were enrolled from outpatient clinics in Karachi, Pakistan. MASC, ferritin, and C-reactive protein (CRP) assays were performed, and results were compared among cases and controls, as well as among children with a case definition of “confirmed TB,” “probable TB,” or “possible TB.” MASC responses were significantly higher among children with TB than among controls (0.41 optical density [OD] versus 0.28 OD, respectively, P < 0.001), and the differences were largely driven by the data from children with confirmed TB ( P = 0.002). Ferritin and CRP values were significantly higher among those with confirmed TB than among those with the other disease states and controls ( P = 0.004 and P = 0.019, respectively). The use of the MASC assay as a blood-based biomarker for TB disease shows some promise among children with microbiologically confirmed disease; however, the performance characteristics for the majority of young children with unconfirmed TB were suboptimal in this cohort. IMPORTANCE Tuberculosis (TB) in children represents a missed opportunity for diagnosis and preventive therapy. The magnitude or burden of disease in children is not fully understood due to our limitations with respect to exploring sensitive diagnostic algorithms. In a setting of TB endemicity in Pakistan, we carried out a proof-of-concept study to evaluate for the first time the performance of B cell analyses by the use of well-defined diagnostic criteria and NIH consensus guidelines as “culture-confirmed,” “probable,” and “possible” TB groups. In contrast to detection of serum antibody, we focused on mycobacterial-antibody-secreting cell (MASC) detection as a marker of active disease in children with a strong suspicion of TB. Further work exploring a larger panel of inflammatory biomarkers and enrichment of B cells with the objective of increasing the sensitivity of the current MASC assay would lead to the development of a field-friendly assay for timely diagnosis of childhood TB. Reliance on microbiologic methods to diagnose infection is a suboptimal approach for children due in part to the paucibacillary nature of the disease. A blood-based biomarker assay, such as the mycobacterial-antibody-secreting cell (MASC) assay, could be a major advance for the field of study of pediatric tuberculosis (TB). Children <15 years of age with clinical concern for TB and age-matched children with no concern for TB were enrolled from outpatient clinics in Karachi, Pakistan. MASC, ferritin, and C-reactive protein (CRP) assays were performed, and results were compared among cases and controls, as well as among children with a case definition of "confirmed TB," "probable TB," or "possible TB." MASC responses were significantly higher among children with TB than among controls (0.41 optical density [OD] versus 0.28 OD, respectively, < 0.001), and the differences were largely driven by the data from children with confirmed TB ( = 0.002). Ferritin and CRP values were significantly higher among those with confirmed TB than among those with the other disease states and controls ( = 0.004 and = 0.019, respectively). The use of the MASC assay as a blood-based biomarker for TB disease shows some promise among children with microbiologically confirmed disease; however, the performance characteristics for the majority of young children with unconfirmed TB were suboptimal in this cohort. Tuberculosis (TB) in children represents a missed opportunity for diagnosis and preventive therapy. The magnitude or burden of disease in children is not fully understood due to our limitations with respect to exploring sensitive diagnostic algorithms. In a setting of TB endemicity in Pakistan, we carried out a proof-of-concept study to evaluate for the first time the performance of B cell analyses by the use of well-defined diagnostic criteria and NIH consensus guidelines as "culture-confirmed," "probable," and "possible" TB groups. In contrast to detection of serum antibody, we focused on mycobacterial-antibody-secreting cell (MASC) detection as a marker of active disease in children with a strong suspicion of TB. Further work exploring a larger panel of inflammatory biomarkers and enrichment of B cells with the objective of increasing the sensitivity of the current MASC assay would lead to the development of a field-friendly assay for timely diagnosis of childhood TB. Tuberculosis (TB) in children represents a missed opportunity for diagnosis and preventive therapy. The magnitude or burden of disease in children is not fully understood due to our limitations with respect to exploring sensitive diagnostic algorithms. In a setting of TB endemicity in Pakistan, we carried out a proof-of-concept study to evaluate for the first time the performance of B cell analyses by the use of well-defined diagnostic criteria and NIH consensus guidelines as “culture-confirmed,” “probable,” and “possible” TB groups. In contrast to detection of serum antibody, we focused on mycobacterial-antibody-secreting cell (MASC) detection as a marker of active disease in children with a strong suspicion of TB. Further work exploring a larger panel of inflammatory biomarkers and enrichment of B cells with the objective of increasing the sensitivity of the current MASC assay would lead to the development of a field-friendly assay for timely diagnosis of childhood TB. ABSTRACT Reliance on microbiologic methods to diagnose Mycobacterium tuberculosis infection is a suboptimal approach for children due in part to the paucibacillary nature of the disease. A blood-based biomarker assay, such as the mycobacterial-antibody-secreting cell (MASC) assay, could be a major advance for the field of study of pediatric tuberculosis (TB). Children <15 years of age with clinical concern for TB and age-matched children with no concern for TB were enrolled from outpatient clinics in Karachi, Pakistan. MASC, ferritin, and C-reactive protein (CRP) assays were performed, and results were compared among cases and controls, as well as among children with a case definition of “confirmed TB,” “probable TB,” or “possible TB.” MASC responses were significantly higher among children with TB than among controls (0.41 optical density [OD] versus 0.28 OD, respectively, P < 0.001), and the differences were largely driven by the data from children with confirmed TB ( P = 0.002). Ferritin and CRP values were significantly higher among those with confirmed TB than among those with the other disease states and controls ( P = 0.004 and P = 0.019, respectively). The use of the MASC assay as a blood-based biomarker for TB disease shows some promise among children with microbiologically confirmed disease; however, the performance characteristics for the majority of young children with unconfirmed TB were suboptimal in this cohort. IMPORTANCE Tuberculosis (TB) in children represents a missed opportunity for diagnosis and preventive therapy. The magnitude or burden of disease in children is not fully understood due to our limitations with respect to exploring sensitive diagnostic algorithms. In a setting of TB endemicity in Pakistan, we carried out a proof-of-concept study to evaluate for the first time the performance of B cell analyses by the use of well-defined diagnostic criteria and NIH consensus guidelines as “culture-confirmed,” “probable,” and “possible” TB groups. In contrast to detection of serum antibody, we focused on mycobacterial-antibody-secreting cell (MASC) detection as a marker of active disease in children with a strong suspicion of TB. Further work exploring a larger panel of inflammatory biomarkers and enrichment of B cells with the objective of increasing the sensitivity of the current MASC assay would lead to the development of a field-friendly assay for timely diagnosis of childhood TB. ABSTRACTReliance on microbiologic methods to diagnose Mycobacterium tuberculosis infection is a suboptimal approach for children due in part to the paucibacillary nature of the disease. A blood-based biomarker assay, such as the mycobacterial-antibody-secreting cell (MASC) assay, could be a major advance for the field of study of pediatric tuberculosis (TB). Children <15 years of age with clinical concern for TB and age-matched children with no concern for TB were enrolled from outpatient clinics in Karachi, Pakistan. MASC, ferritin, and C-reactive protein (CRP) assays were performed, and results were compared among cases and controls, as well as among children with a case definition of “confirmed TB,” “probable TB,” or “possible TB.” MASC responses were significantly higher among children with TB than among controls (0.41 optical density [OD] versus 0.28 OD, respectively, P < 0.001), and the differences were largely driven by the data from children with confirmed TB (P = 0.002). Ferritin and CRP values were significantly higher among those with confirmed TB than among those with the other disease states and controls (P = 0.004 and P = 0.019, respectively). The use of the MASC assay as a blood-based biomarker for TB disease shows some promise among children with microbiologically confirmed disease; however, the performance characteristics for the majority of young children with unconfirmed TB were suboptimal in this cohort.IMPORTANCE Tuberculosis (TB) in children represents a missed opportunity for diagnosis and preventive therapy. The magnitude or burden of disease in children is not fully understood due to our limitations with respect to exploring sensitive diagnostic algorithms. In a setting of TB endemicity in Pakistan, we carried out a proof-of-concept study to evaluate for the first time the performance of B cell analyses by the use of well-defined diagnostic criteria and NIH consensus guidelines as “culture-confirmed,” “probable,” and “possible” TB groups. In contrast to detection of serum antibody, we focused on mycobacterial-antibody-secreting cell (MASC) detection as a marker of active disease in children with a strong suspicion of TB. Further work exploring a larger panel of inflammatory biomarkers and enrichment of B cells with the objective of increasing the sensitivity of the current MASC assay would lead to the development of a field-friendly assay for timely diagnosis of childhood TB. |
Author | Qamar, Farah N Ahmed, Kumail Arif, Fehmina Thomas, Tania Sultana, Shazia Houpt, Eric Raza, Syeda Fatima Siddiqi, Shakil Ahmad Shaheen, Fariha Saeed, Amna Afzal Qureshi, Shahida Mumtaz Iqbal, Najeeha Talat Yousuf, Aneeq Muhammad Mehnaz, Aisha |
Author_xml | – sequence: 1 givenname: Najeeha Talat surname: Iqbal fullname: Iqbal, Najeeha Talat email: najeeha.iqbal@aku.edu organization: Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan – sequence: 2 givenname: Kumail surname: Ahmed fullname: Ahmed, Kumail organization: Department of Paediatrics, Aga Khan University, Karachi, Pakistan – sequence: 3 givenname: Farah N surname: Qamar fullname: Qamar, Farah N organization: Department of Paediatrics, Aga Khan University, Karachi, Pakistan – sequence: 4 givenname: Fariha surname: Shaheen fullname: Shaheen, Fariha organization: Department of Paediatrics, Aga Khan University, Karachi, Pakistan – sequence: 5 givenname: Aisha surname: Mehnaz fullname: Mehnaz, Aisha organization: Paediatric Ward I, Civil Hospital Karachi, Karachi, Pakistan – sequence: 6 givenname: Fehmina surname: Arif fullname: Arif, Fehmina organization: Paediatric Ward I, Civil Hospital Karachi, Karachi, Pakistan – sequence: 7 givenname: Amna Afzal surname: Saeed fullname: Saeed, Amna Afzal organization: School of Medicine, Aga Khan University, Karachi, Pakistan – sequence: 8 givenname: Aneeq Muhammad surname: Yousuf fullname: Yousuf, Aneeq Muhammad organization: School of Medicine, Aga Khan University, Karachi, Pakistan – sequence: 9 givenname: Syeda Fatima surname: Raza fullname: Raza, Syeda Fatima organization: School of Medicine, Aga Khan University, Karachi, Pakistan – sequence: 10 givenname: Shazia surname: Sultana fullname: Sultana, Shazia organization: Department of Paediatrics, Aga Khan University, Karachi, Pakistan – sequence: 11 givenname: Shahida Mumtaz surname: Qureshi fullname: Qureshi, Shahida Mumtaz organization: Department of Paediatrics, Aga Khan University, Karachi, Pakistan – sequence: 12 givenname: Shakil Ahmad surname: Siddiqi fullname: Siddiqi, Shakil Ahmad organization: Sindh Government Hospital Korangi, Karachi, Pakistan – sequence: 13 givenname: Eric surname: Houpt fullname: Houpt, Eric organization: Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA – sequence: 14 givenname: Tania surname: Thomas fullname: Thomas, Tania organization: Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32024709$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkstvEzEQxi1UREvonRNaiQuXLX7s-nFBqsIrUhFILWfLa88mDrt2sL1I-e_ZJqFqOXlkf_Ob8cz3Ep2FGACh1wRfEULl-_F2t4EEVxhzRmuinqELyoSqW9zQs0fxObrMeYsxJpxyLvgLdM4opo3A6gKZ61B8F92-vgWboPiwrpYwDLm6i9VHb9YhZqi-7W3sjC2Q_DRWZeog2WmI2edqFXqwxcdQ-VAtN35wCQ7xD_PL52LCK_S8N0OGy9O5QD8_f7pbfq1vvn9ZLa9vatsoXGopeulaZ5ghQlDJjLHSqq6XqhXCEi4aAkwJhokFS6lylEDPJfSkl63rGrZAqyPXRbPVu-RHk_Y6Gq8PFzGttUnF2wG0ctZQ00KHOWmEPZThDSg-88VMnlkfjqzd1I3gLISSzPAE-vQl-I1exz9aYEzZvI8FencCpPh7glz06LOd52oCxClrylqKW8Kb-77f_ifdximFeVSzikuuiGrxrMJHlU0x5wT9QzME63s76JMd9MEOmqg55c3jTzwk_Fs--wsSKrSk |
CitedBy_id | crossref_primary_10_2147_IDR_S295798 crossref_primary_10_1155_2020_8235149 |
Cites_doi | 10.1128/CVI.00501-12 10.5588/ijtld.15.0471 10.1371/journal.pone.0169118 10.1371/journal.pone.0064226 10.3389/fimmu.2019.01317 10.1136/thoraxjnl-2012-201817 10.1128/JCM.26.11.2313-2318.1988 10.1136/thoraxjnl-2015-207999 10.1111/imm.13023 10.1086/376511 10.1179/2046905512Y.0000000008 10.1371/journal.pone.0016425 10.1371/journal.pmed.1001012 10.1371/journal.pone.0126863 10.18632/oncotarget.11420 10.1093/infdis/jis008 10.1128/CVI.00391-08 10.1186/1472-6963-11-187 10.4103/2320-8775.126504 10.1016/j.cyto.2019.154773 10.1128/CDLI.11.6.1022-1027.2004 10.1136/thx.2010.147363 10.1016/s0022-3476(97)70200-2 10.1371/journal.pone.0097992 10.1128/CDLI.2.6.726-732.1995 10.1182/blood-2004-07-2507 10.1088/1752-7163/11/1/016003 10.1093/cid/civ613 10.1093/cid/ciu945 |
ContentType | Journal Article |
Copyright | Copyright © 2020 Iqbal et al. Copyright © 2020 Iqbal et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © 2020 Iqbal et al. 2020 Iqbal et al. |
Copyright_xml | – notice: Copyright © 2020 Iqbal et al. – notice: Copyright © 2020 Iqbal et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © 2020 Iqbal et al. 2020 Iqbal et al. |
DBID | NPM AAYXX CITATION 3V. 7X7 7XB 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M7P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1128/mSphere.00632-19 |
DatabaseName | PubMed CrossRef ProQuest Central (Corporate) Health & Medical Collection (Proquest) ProQuest Central (purchase pre-March 2016) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) Biological Science Database Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef Publicly Available Content Database ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | PubMed CrossRef Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | Immune Biomarkers of Pediatric TB |
EISSN | 2379-5042 |
Editor | Achkar, Jacqueline M. |
Editor_xml | – sequence: 1 givenname: Jacqueline M. surname: Achkar fullname: Achkar, Jacqueline M. |
ExternalDocumentID | oai_doaj_org_article_9dca2a5eb06147cc9bf864e9697379d2 10_1128_mSphere_00632_19 32024709 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Bangladesh Pakistan |
GeographicLocations_xml | – name: Pakistan – name: Bangladesh |
GrantInformation_xml | – fundername: ; grantid: 51543 |
GroupedDBID | 0R~ 3V. 53G 5VS 7X7 8FE 8FH 8FI 8FJ AAFWJ AAUOK ABUWG ADBBV AFKRA AFPKN ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CCPQU DIK EBS FRP FYUFA GROUPED_DOAJ H13 HCIFZ HMCUK HYE KQ8 LK8 M48 M7P M~E NPM O9- OK1 PGMZT PIMPY PQQKQ PROAC R9- RHF RHI RPM RSF UKHRP AAYXX CITATION 7XB 8FK AZQEC DWQXO GNUQQ K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c490t-87f8d5da3a177283aac8c9bf89577c16741e397301cec229d21ef68ef1f85db43 |
IEDL.DBID | RPM |
ISSN | 2379-5042 |
IngestDate | Tue Oct 22 15:14:24 EDT 2024 Tue Sep 17 21:31:08 EDT 2024 Fri Oct 25 05:17:37 EDT 2024 Sat Nov 09 15:49:11 EST 2024 Fri Aug 23 01:13:04 EDT 2024 Sat Sep 28 08:30:07 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | antibody-secreting cells biomarkers tuberculosis |
Language | English |
License | Copyright © 2020 Iqbal et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c490t-87f8d5da3a177283aac8c9bf89577c16741e397301cec229d21ef68ef1f85db43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Citation Iqbal NT, Ahmed K, Qamar FN, Shaheen F, Mehnaz A, Arif F, Saeed AA, Yousuf AM, Raza SF, Sultana S, Qureshi SM, Siddiqi SA, Houpt E, Thomas T. 2020. Antibody-secreting cells to diagnose Mycobacterium tuberculosis infection in children in Pakistan. mSphere 5:e00632-19. https://doi.org/10.1128/mSphere.00632-19. |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002306/ |
PMID | 32024709 |
PQID | 2368691950 |
PQPubID | 2045592 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_9dca2a5eb06147cc9bf864e9697379d2 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7002306 proquest_miscellaneous_2352051644 proquest_journals_2368691950 crossref_primary_10_1128_mSphere_00632_19 pubmed_primary_32024709 |
PublicationCentury | 2000 |
PublicationDate | 20200205 |
PublicationDateYYYYMMDD | 2020-02-05 |
PublicationDate_xml | – month: 2 year: 2020 text: 20200205 day: 5 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Washington – name: 1752 N St., N.W., Washington, DC |
PublicationTitle | mSphere |
PublicationTitleAlternate | mSphere |
PublicationYear | 2020 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_28_2 e_1_3_2_20_2 WHO (e_1_3_2_12_2) 2014 e_1_3_2_21_2 e_1_3_2_23_2 e_1_3_2_24_2 Mehnaz A (e_1_3_2_22_2) 2006; 56 e_1_3_2_25_2 Naher N (e_1_3_2_29_2) 2015; 24 WHO (e_1_3_2_38_2) 2016 e_1_3_2_9_2 e_1_3_2_15_2 WHO (e_1_3_2_2_2) 2018 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 Lewinsohn DA (e_1_3_2_18_2) 2004; 8 e_1_3_2_4_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_14_2 e_1_3_2_35_2 National TB Control Programme, Federal Ministry of Health (e_1_3_2_34_2) 2006 |
References_xml | – volume: 8 start-page: 658 year: 2004 ident: e_1_3_2_18_2 article-title: Tuberculosis immunology in children: diagnostic and therapeutic challenges and opportunities publication-title: Int J Tuber Lung Dis contributor: fullname: Lewinsohn DA – ident: e_1_3_2_20_2 doi: 10.1128/CVI.00501-12 – ident: e_1_3_2_3_2 doi: 10.5588/ijtld.15.0471 – ident: e_1_3_2_8_2 doi: 10.1371/journal.pone.0169118 – ident: e_1_3_2_11_2 doi: 10.1371/journal.pone.0064226 – ident: e_1_3_2_19_2 doi: 10.3389/fimmu.2019.01317 – ident: e_1_3_2_7_2 doi: 10.1136/thoraxjnl-2012-201817 – ident: e_1_3_2_17_2 doi: 10.1128/JCM.26.11.2313-2318.1988 – ident: e_1_3_2_25_2 doi: 10.1136/thoraxjnl-2015-207999 – ident: e_1_3_2_23_2 – volume: 24 start-page: 756 year: 2015 ident: e_1_3_2_29_2 article-title: Serum C-reactive protein (CRP) level in tuberculous patients publication-title: Mymensingh Med J contributor: fullname: Naher N – ident: e_1_3_2_30_2 doi: 10.1111/imm.13023 – ident: e_1_3_2_5_2 doi: 10.1086/376511 – volume-title: Global tuberculosis report 2018 year: 2018 ident: e_1_3_2_2_2 contributor: fullname: WHO – ident: e_1_3_2_33_2 doi: 10.1179/2046905512Y.0000000008 – ident: e_1_3_2_6_2 doi: 10.1371/journal.pone.0016425 – ident: e_1_3_2_15_2 doi: 10.1371/journal.pmed.1001012 – ident: e_1_3_2_10_2 doi: 10.1371/journal.pone.0126863 – volume-title: The WHO child growth standards year: 2016 ident: e_1_3_2_38_2 contributor: fullname: WHO – ident: e_1_3_2_26_2 doi: 10.18632/oncotarget.11420 – ident: e_1_3_2_37_2 doi: 10.1093/infdis/jis008 – ident: e_1_3_2_9_2 doi: 10.1128/CVI.00391-08 – volume-title: High-priority target product profiles for new tuberculosis diagnostics: report of a consensus meeting year: 2014 ident: e_1_3_2_12_2 contributor: fullname: WHO – ident: e_1_3_2_35_2 doi: 10.1186/1472-6963-11-187 – ident: e_1_3_2_24_2 doi: 10.4103/2320-8775.126504 – ident: e_1_3_2_27_2 doi: 10.1016/j.cyto.2019.154773 – ident: e_1_3_2_14_2 doi: 10.1128/CDLI.11.6.1022-1027.2004 – ident: e_1_3_2_13_2 doi: 10.1136/thx.2010.147363 – ident: e_1_3_2_21_2 doi: 10.1016/s0022-3476(97)70200-2 – volume: 56 start-page: 390 year: 2006 ident: e_1_3_2_22_2 article-title: Tuberculosis in children publication-title: J Pak Med Assoc contributor: fullname: Mehnaz A – ident: e_1_3_2_31_2 doi: 10.1371/journal.pone.0097992 – ident: e_1_3_2_36_2 doi: 10.1128/CDLI.2.6.726-732.1995 – ident: e_1_3_2_16_2 doi: 10.1182/blood-2004-07-2507 – ident: e_1_3_2_28_2 doi: 10.1088/1752-7163/11/1/016003 – ident: e_1_3_2_4_2 doi: 10.1093/cid/civ613 – volume-title: National guidelines for diagnosis and management of tuberculosis in children NTP Pakistan year: 2006 ident: e_1_3_2_34_2 contributor: fullname: National TB Control Programme, Federal Ministry of Health – ident: e_1_3_2_32_2 doi: 10.1093/cid/ciu945 |
SSID | ssj0001626676 |
Score | 2.1708236 |
Snippet | Reliance on microbiologic methods to diagnose
infection is a suboptimal approach for children due in part to the paucibacillary nature of the disease. A... Tuberculosis (TB) in children represents a missed opportunity for diagnosis and preventive therapy. The magnitude or burden of disease in children is not fully... ABSTRACTReliance on microbiologic methods to diagnose Mycobacterium tuberculosis infection is a suboptimal approach for children due in part to the... ABSTRACT Reliance on microbiologic methods to diagnose Mycobacterium tuberculosis infection is a suboptimal approach for children due in part to the... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
SubjectTerms | Age antibody-secreting cells Antigens Biomarkers C-reactive protein Cell culture Children Clinical Science and Epidemiology Diagnosis Ferritin Immunoglobulins Inflammation Lymphocytes B Malnutrition Mycobacterium tuberculosis Optical density Pediatrics Tuberculosis Vaccines |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagEhIXBOUVKMhIXDhEXdtJbB_LtlV7KJctEjfLj4lYaZugZnPYf4_HTqNdhMSFWxT7MJnJjL-xx98Q8nkBUDOrdAmBtWVVaVZqJ5EJ03FgguFeP25drOS3H-r8Amly5lZfWBOW6YGz4k518JbbGhymLtJ77VrVVKAbLYXUIUffhdpLptLuSsTpjZzPJbk6vVvhNX3AOi7BSyTW2VuHEl3_3zDmn6WSe2vP5XPybAKN9CwL-4I8gu6YPMltJHcviT3rtmvXh125QhCIhcx0CZvNQG97ep5r6YDe7Hz03cTNPN7R7ejg3o-bflgP9HqqyOrouqPL6Xo3Pk_4sntFvl9e3C6vyql1QukrvdjGGNeqUAcrLIvwWQlrvUqq07WUHm8eMIhIJHq3B8951CODtlHQslbVwVXiNTnq-g7eEtpCAIc8Y1KISjqhHBOu1sI14AXItiBfHhRpfmWGDJMyC67MpHSTlG6YLshX1PQ8D7mt04tocTNZ3PzL4gU5ebCTmRxuMFw0qtHY07Ygn-bh6Cp4_mE76EecU_MYgyICLMibbNZZEmwjX8lFlFAeGPxA1MORbv0z0XHLnMe9-x_f9p485ZjQY1l4fUKOtvcjfCCPhzB-TD_4b1ROAjg priority: 102 providerName: Directory of Open Access Journals |
Title | Antibody-Secreting Cells To Diagnose Mycobacterium tuberculosis Infection in Children in Pakistan |
URI | https://www.ncbi.nlm.nih.gov/pubmed/32024709 https://www.proquest.com/docview/2368691950 https://search.proquest.com/docview/2352051644 https://pubmed.ncbi.nlm.nih.gov/PMC7002306 https://doaj.org/article/9dca2a5eb06147cc9bf864e9697379d2 |
Volume | 5 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pa9swFBZLYbDL2Nr9cNcFFXbZwU0l2ZZ07NKWldExSAe7GUt-3gyJXOL4kP9-erIdkrFTb8aW4SE9Sd97-t4nQj5dAqSsUDqGklVxkmgWayNRCdNwYIJhrh9TFwv5_Ze6vkGZnHSshQmkfWvqC7dcXbj6T-BWPq7sbOSJzX7cz2WPnGcTMvHYcC9ED4kVD9EzuTuS5Gq2WmCFPiCFS_CYoVAo3hqeSGQh7u1GQbT_f0jzX8Lk3g50-4q8HKAjvepNfE2egTsmz_vLJLcnpLhym9o05TZeIBREOjOdw3LZ0oeGXveMOqD3W-tncFBo7lZ00xlY227ZtHVL7wZelqO1o_OhyBufB5Tp3pCftzcP86_xcIFCbBN9ufErXaXKtCxEwTyIVqIorLLaVEqnUlqsP2Dg8Yif4xYs57rkDKpMQcUqlZYmEW_JkWscvCe0ghIMqo1JIRJphDJMmFQLk4EVIKuIfB47Mn_sdTLyEF9wlQ_9n4f-z5mOyBfs6V07VLgOL5r173wY51yXtuBFCgZDVmmD2VkCOvP2Sm9pRM7GccqHadfmXGQq03izbUTOd5_9hMFTkMJB02GblPuVyOPAiLzrh3VnyegWEZEHA35g6uEX76NBlHvwydMn__mBvOAYyyMjPD0jR5t1Bx_JpC27qYf6d9-mIV0wDc7-FwMxBDs |
link.rule.ids | 230,315,729,782,786,866,887,2108,27935,27936,53803,53805 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFLbYEILL-M0CA4LEhUPW2k5i-zi6TZtYJ6QWiZsVOy8jUptMTXPof4-fk1Qt4rRbFDvSU9579mf7e58J-ToGSGgmVQQ5LaI4VjRSRqASpmFAOcW9fty6mInb3_L8AmVykqEWxpP2rSlPq8XytCr_eG7l_dKOBp7Y6Od0IjrkPDogj12-jvnOIt1vrTiQnortoSSTo-UMa_QBSVycRRSlQvHe8FggD3FnPvKy_f_Dmv9SJnfmoMvnD7T-BTnqQWd41jW_JI-gekWedNdQbl6T7Kxal6bON9EMQSQSocMJLBZNOK_D846LB-F0Y13ue23ndhmuWwMr2y7qpmzC657RVYVlFU768nB87vFp9Yb8uryYT66i_uqFyMZqvHZjZCHzJM94Rh38ljzLrLTKFFIlQlisXKDgkIwbHSxYxlTOKBSphIIWMslNzN-Sw6qu4JiEBeRgUKdMcB4Lw6Wh3CSKmxQsB1EE5NvgAH3fKWxovzJhUvd-095vmqqAfEcPbfuhNrZ_Ua_udP-PtcptxrIEDC52hfVmpzGo1NkrnKUBORn8q_uEbTTjqUwV3okbkC_bZpdqeH6SVVC32CdhbgxzCDIg77pw2FoyhFNAxF6g7Jm63-Liw8t59_Hw_sFffiZPr-bTG31zffvjA3nGcEcAeeXJCTlcr1r4SA6avP3kk-QvlHoXyg |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Pb9MwFLbYEGgXfsMCA4LEhUOW2k5i-zjaVUywaVKHxM2KnReI1CZV0xz63-PnpFWLOMEtShzpJe_Z_vz8-XuEfBwBpDSXKoKCllGSKBopI1AJ0zCgnGKuH1MXM3HzQ04uUSZnV-rLk_atqc7r-eK8rn55buVyYeMtTyy-vR6LHjnHy6KMj8h912dH6d5C3adXHFDPxG5jksl4McNz-oBELs4iinKhWDs8EchF3JuTvHT_3_Dmn7TJvXlo-vg_vuAJeTSAz_Cib_KU3IP6GXnQl6PcPCf5Rb2uTFNsohmCSSREh2OYz9vwrgknPScPwuuNdWOA13juFuG6M7Cy3bxpqza8GphddVjV4Xg4Jo7XA06tX5Dv08u78ZdoKMEQ2USN1m6sLGWRFjnPqYPhkue5lVaZUqpUCIsnGCg4RONGCQuWMVUwCmUmoaSlTAuT8JfkuG5qOCVhCQUY1CsTnCfCcGkoN6niJgPLQZQB-bR1gl72Shvar1CY1IPvtPedpiogn9FLu3aoke1vNKufevjPWhU2Z3kKBhe9wnqzswRU5uwVztKAnG19rIeO22rGM5kprI0bkA-7x67L4T5KXkPTYZuUubHMIcmAvOpDYmfJNqQCIg6C5cDUwycuRrys9xATr__5zffk4e1kqr9d3Xx9Q04YJgaQXp6ekeP1qoO35Kgtune-n_wGTxgaSg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antibody-Secreting+Cells+To+Diagnose+Mycobacterium+tuberculosis+Infection+in+Children+in+Pakistan&rft.jtitle=mSphere&rft.au=Iqbal%2C+Najeeha+Talat&rft.au=Kumail%2C+Ahmed&rft.au=Qamar%2C+Farah+N&rft.au=Shaheen+Fariha&rft.date=2020-02-05&rft.pub=American+Society+for+Microbiology&rft.eissn=2379-5042&rft.volume=5&rft.issue=1&rft_id=info:doi/10.1128%2FmSphere.00632-19&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2379-5042&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2379-5042&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2379-5042&client=summon |